Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Inga svenska företag i topp 50

Varje år sammanställer Boston Consulting Group en lista över världens 50 mest innovativa företag. Inga svenska företag finns representerade på årets lista som t...

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Ny design på klinstudie

I ett samarbete mellan FDA, NIH och läkemedelsindustrin utvärderas ett flertal behandlingar i samma studie.

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

Han vill fånga koldioxid med elektricitet

Hallå där Peter Zerhouni…

… som tillträdde som vd på biotechföretaget Index Pharmaceuticals tisdagen 1 april. Vad tar du med dig från din förra tjänst, som vd på vaccinbolaget Diamyd?

Ny teknik kan upptäcka alzheimer tidigare

Detektion av specifika former av proteinet tau i blodprover kan ge tidigare diagnostik av personer med alzheimer, redan innan de första symptomen uppstår.

Köper upp AI-teknik för embryon

Vitrolife i avtal med australiska bolag.

EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

”Det börjar dyka upp produkter på marknaden som inte ska vara där”

Aldrig har utvecklingen av diagnostik gått så snabbt som nu och nya självtester för covid-19 dyker upp i snabb takt. Samtidigt slinker självtester som inte leve...

Fusion between pharma giants?

It is rumoured that a fusion between Pfizer and Wyeth is in the process of happening.

Samuel Lagercrantz: Framgången kommer efter många misslyckanden

De allra flesta av de idéer och strategier mot covid-19 som man nu jobbar med kommer att gå i stöpet, men det kan räcka med att en enda fungerar, skriver Samuel Lagercrantz.

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...

Transatlantic cooperation for healthier food

Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.

Transatlantic cooperation for healthier food

Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

New CEO to Promedvi

Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.

Clinical trials in large scale to Stockholm

Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...

New CEO to Medivir

The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.

Many rotor options for refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Multiple rotor options in refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Biogaia's advance goes on

In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.